American CryoStem Corporation
CRYO · OTC
9/30/2021 | 9/30/2020 | 9/30/2019 | 9/30/2018 | |
|---|---|---|---|---|
| Revenue | $21 | $558 | $322 | $1,103 |
| % Growth | -96.3% | 73.5% | -70.8% | – |
| Cost of Goods Sold | $14 | $44 | $32 | $297 |
| Gross Profit | $7 | $514 | $290 | $806 |
| % Margin | 34.1% | 92.1% | 90.1% | 73.1% |
| R&D Expenses | $447 | $93 | $381 | $521 |
| G&A Expenses | $1,759 | $968 | $826 | $1,455 |
| SG&A Expenses | $1,765 | $989 | $860 | $1,526 |
| Sales & Mktg Exp. | $6 | $26 | $34 | $71 |
| Other Operating Expenses | -$0 | $0 | $4 | $0 |
| Operating Expenses | $2,212 | $1,389 | $1,245 | $2,079 |
| Operating Income | -$2,205 | -$589 | -$951 | -$1,273 |
| % Margin | -10,710.6% | -105.6% | -295.7% | -115.3% |
| Other Income/Exp. Net | -$674 | -$590 | -$131 | -$218 |
| Pre-Tax Income | -$2,880 | -$1,179 | -$1,082 | -$1,491 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2,880 | -$1,179 | -$1,082 | -$1,491 |
| % Margin | -13,985.4% | -211.4% | -336.5% | -135.1% |
| EPS | -0.05 | -0.02 | -0.02 | -0.03 |
| % Growth | -149.5% | 0% | 33.3% | – |
| EPS Diluted | -0.05 | -0.02 | -0.02 | -0.03 |
| Weighted Avg Shares Out | 60,342 | 51,660 | 48,916 | 46,216 |
| Weighted Avg Shares Out Dil | 60,342 | 51,660 | 48,916 | 46,216 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $104 | $304 | $130 | $100 |
| Depreciation & Amortization | $69 | $340 | $47 | $27 |
| EBITDA | -$2,165 | -$521 | -$908 | -$1,213 |
| % Margin | -10,513.2% | -93.4% | -282.4% | -110% |